BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

325 related articles for article (PubMed ID: 25273558)

  • 1. Predicting interactome network perturbations in human cancer: application to gene fusions in acute lymphoblastic leukemia.
    Hajingabo LJ; Daakour S; Martin M; Grausenburger R; Panzer-Grümayer R; Dequiedt F; Simonis N; Twizere JC
    Mol Biol Cell; 2014 Dec; 25(24):3973-85. PubMed ID: 25273558
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical features and prognostic implications of TCF3-PBX1 and ETV6-RUNX1 in adult acute lymphoblastic leukemia.
    Burmeister T; Gökbuget N; Schwartz S; Fischer L; Hubert D; Sindram A; Hoelzer D; Thiel E
    Haematologica; 2010 Feb; 95(2):241-6. PubMed ID: 19713226
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Flow cytometric predictive scoring systems for common fusions ETV6/RUNX1, BCR/ABL1, TCF3/PBX1 and rearrangements of the KMT2A gene, proposed for the initial cytogenetic approach in cases of B-acute lymphoblastic leukemia.
    Tsagarakis NJ; Papadhimitriou SI; Pavlidis D; Marinakis T; Kostopoulos IV; Stiakaki E; Polychronopoulou S; Paterakis G
    Int J Lab Hematol; 2019 Jun; 41(3):364-372. PubMed ID: 30730614
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of Two Quantitative PCR-Based Assays for Detection of Minimal Residual Disease in B-Precursor Acute Lymphoblastic Leukemia Harboring Three Major Fusion Transcripts.
    Huang YJ; Kuo MC; Jaing TH; Liu HC; Yeh TC; Chen SH; Lin TL; Yang CP; Wang PN; Sheen JM; Chang TK; Chang CH; Hu SF; Huang TY; Wang SC; Wu KH; Chiou SS; Hsiao CC; Shih LY
    J Mol Diagn; 2021 Oct; 23(10):1373-1379. PubMed ID: 34325057
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Integrative epigenomic analysis identifies biomarkers and therapeutic targets in adult B-acute lymphoblastic leukemia.
    Geng H; Brennan S; Milne TA; Chen WY; Li Y; Hurtz C; Kweon SM; Zickl L; Shojaee S; Neuberg D; Huang C; Biswas D; Xin Y; Racevskis J; Ketterling RP; Luger SM; Lazarus H; Tallman MS; Rowe JM; Litzow MR; Guzman ML; Allis CD; Roeder RG; Müschen M; Paietta E; Elemento O; Melnick AM
    Cancer Discov; 2012 Nov; 2(11):1004-23. PubMed ID: 23107779
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Frequency of the ETV6-RUNX1, BCR-ABL1, TCF3-PBX1, and MLL-AFF1 fusion genes in Guatemalan pediatric acute lymphoblastic leukemia patients and their ethnic associations.
    Carranza C; Granados L; Morales O; Jo W; Villagran S; Tinti D; Villegas M; Antillón F; Torselli S; Silva G
    Cancer Genet; 2013 Jun; 206(6):227-32. PubMed ID: 23859904
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CRLF2 and IKZF1 abnormalities in Mexican children with acute lymphoblastic leukemia and recurrent gene fusions: exploring surrogate markers of signaling pathways.
    Moreno Lorenzana D; Juárez Velázquez MDR; Reyes León A; Martínez Anaya D; Hernández Monterde A; Salas Labadía C; Navarrete Meneses MDP; Zapata Tarrés M; Juárez Villegas L; Jarquín Ramírez B; Cárdenas Cardós R; Herrera Almanza M; Paredes Aguilera R; Pérez Vera P
    J Pathol Clin Res; 2021 Jul; 7(4):410-421. PubMed ID: 33890726
    [TBL] [Abstract][Full Text] [Related]  

  • 8. BCR-ABL, ETV6-RUNX1 and E2A-PBX1: prevalence of the most common acute lymphoblastic leukemia fusion genes in Mexican patients.
    Jiménez-Morales S; Miranda-Peralta E; Saldaña-Alvarez Y; Perez-Vera P; Paredes-Aguilera R; Rivera-Luna R; Velázquez-Cruz R; Ramírez-Bello J; Carnevale A; Orozco L
    Leuk Res; 2008 Oct; 32(10):1518-22. PubMed ID: 18455790
    [TBL] [Abstract][Full Text] [Related]  

  • 9. E2A-PBX1 functions as a coactivator for RUNX1 in acute lymphoblastic leukemia.
    Pi WC; Wang J; Shimada M; Lin JW; Geng H; Lee YL; Lu R; Li D; Wang GG; Roeder RG; Chen WY
    Blood; 2020 Jul; 136(1):11-23. PubMed ID: 32276273
    [TBL] [Abstract][Full Text] [Related]  

  • 10. ETV6-RUNX1 interacts with a region in SPIB intron 1 to regulate gene expression in pre-B-cell acute lymphoblastic leukemia.
    Xu LS; Francis A; Turkistany S; Shukla D; Wong A; Batista CR; DeKoter RP
    Exp Hematol; 2019 May; 73():50-63.e2. PubMed ID: 30986496
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High incidence of RAS pathway mutations among sentinel genetic lesions of Korean pediatric BCR-ABL1-like acute lymphoblastic leukemia.
    Lee JW; Kim Y; Cho B; Kim S; Jang PS; Lee J; Cho H; Lee GD; Chung NG; Kim M
    Cancer Med; 2020 Jul; 9(13):4632-4639. PubMed ID: 32378810
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regulation of the miRNA expression by TEL/AML1, BCR/ABL, MLL/AF4 and TCF3/PBX1 oncoproteins in acute lymphoblastic leukemia (Review).
    Organista-Nava J; Gómez-Gómez Y; Illades-Aguiar B; Leyva-Vázquez MA
    Oncol Rep; 2016 Sep; 36(3):1226-32. PubMed ID: 27431573
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Emerging molecular subtypes and therapies in acute lymphoblastic leukemia.
    Davis K; Sheikh T; Aggarwal N
    Semin Diagn Pathol; 2023 May; 40(3):202-215. PubMed ID: 37120350
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostically significant fusion oncogenes in Pakistani patients with adult acute lymphoblastic leukemia and their association with disease biology and outcome.
    Sabir N; Iqbal Z; Aleem A; Awan T; Naeem T; Asad S; Tahir AH; Absar M; Hasanato RM; Basit S; Chishti MA; Faiyaz Ul-Haque M; Khalid AM; Sabar MF; Rasool M; Karim S; Khan M; Samreen B; Akram AM; Siddiqi MH; Shahzadi S; Shahbaz S; Ali AS; Mahmood A; Akram M; Saeed T; Saleem A; Mohsin D; Shah IH; Khalid M; Asif M; Iqbal M; Akhtar T
    Asian Pac J Cancer Prev; 2012; 13(7):3349-55. PubMed ID: 22994759
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Direct and indirect targets of the E2A-PBX1 leukemia-specific fusion protein.
    Diakos C; Xiao Y; Zheng S; Kager L; Dworzak M; Wiemels JL
    PLoS One; 2014; 9(2):e87602. PubMed ID: 24503810
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Normal and Aberrant TALE-Class Homeobox Gene Activities in Pro-B-Cells and B-Cell Precursor Acute Lymphoblastic Leukemia.
    Nagel S; Meyer C
    Int J Mol Sci; 2022 Oct; 23(19):. PubMed ID: 36233173
    [TBL] [Abstract][Full Text] [Related]  

  • 17. ETV6/RUNX1 transcript is a target of RNA-binding protein IGF2BP1 in t(12;21)(p13;q22)-positive acute lymphoblastic leukemia.
    Stoskus M; Vaitkeviciene G; Eidukaite A; Griskevicius L
    Blood Cells Mol Dis; 2016 Mar; 57():30-4. PubMed ID: 26852652
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Autophagy inhibition as a potential future targeted therapy for ETV6-RUNX1-driven B-cell precursor acute lymphoblastic leukemia.
    Polak R; Bierings MB; van der Leije CS; Sanders MA; Roovers O; Marchante JRM; Boer JM; Cornelissen JJ; Pieters R; den Boer ML; Buitenhuis M
    Haematologica; 2019 Apr; 104(4):738-748. PubMed ID: 30381299
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Constitutive 53BP1/γH2AX foci are increased in cells of ALL patients dependent on BCR-ABL and TEL-AML1 preleukemic gene fusions.
    Somsedikova A; Markova E; Kolenova A; Puskacova J; Kubes M; Belyaev I
    Neoplasma; 2014; 61(5):617-25. PubMed ID: 25244981
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Five most common prognostically important fusion oncogenes are detected in the majority of Pakistani pediatric acute lymphoblastic leukemia patients and are strongly associated with disease biology and treatment outcome.
    Awan T; Iqbal Z; Aleem A; Sabir N; Absar M; Rasool M; Tahir AH; Basit S; Khalid AM; Sabar MF; Asad S; Ali AS; Mahmood A; Akram M; Saeed T; Saleem A; Mohsin D; Shah IH; Khalid M; Asif M; Haq R; Iqbal M; Akhtar T
    Asian Pac J Cancer Prev; 2012; 13(11):5469-75. PubMed ID: 23317202
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.